神経毒の世界市場レポート 2024

神経毒の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には10.7%の年間複合成長率（CAGR）で111億4,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、神経学における応用の拡大、美容処置に対する持続的な需要、製剤の革新、消費者の意識の向上、および化粧品観光の拡大に起因すると考えられます。予測期間中に予想される注目すべき動向には、ドラッグデリバリー技術の進歩、神経毒の開発と調査のためのコラボレーション、神経毒業界の規制変更に対する市場の反応、集学的治療計画への神経毒の統合、および長期持続効果の達成への重点の強化、患者の満足が含まれます。

神経毒市場で予想される成長は、外観の改善を目的とした美容処置の急増によって促進されると予想されます。美容処置には、個人の外見を改善または変更することを主な目的として行われるさまざまな医療介入が含まれます。この傾向は、美容処置に関連する利点に対する意識の高まりと相まって、社会的、技術的、文化的要因の影響を受けています。 神経毒は、特定の筋肉を弛緩させることでこれらの処置において重要な役割を果たし、それによってしわや小じわの出現を軽減します。たとえば、2022年 8月に米国形成外科医協会が行った美容外科に関する調査では、米国の形成外科医の4人に3人が需要の増加を指摘し、30%が美容処置の需要が2倍になったと報告しています。彼らの美容整形ビジネス。外観を改善するための美容処置のこの急増は、神経毒市場の成長を促進する重要な推進力です。

高齢化の進展により、神経毒市場の拡大が期待されています。「高齢化人口」という用語は、社会または人口内の高齢者の割合の増加を特徴とする人口動態を指します。年齢を重ねると、しわやフェイスラインなどの加齢に伴う美容上の悩みに対処するために、ボトックスなどの神経毒ベースの治療に頼ることがよくあります。この層は、見た目を改善し、より若々しく若返った美学を実現するための非侵襲的なソリューションを求めています。世界保健機関（WHO）によると、世界の60歳以上の人口は急速に増加しており、2050年までに倍増して21億人に達すると予想されています。したがって、高齢化人口の増加は、神経毒市場の成長を促進する重要な要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の神経毒市場、製品タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• ボトックス
• ディスポート
• ソミン
• その他の製品
• 世界の神経毒市場、用途別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 治療
• 美容
• 世界の神経毒市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 病院
• 専門クリニック
• 皮膚科クリニック
• その他のエンドユーザー

第7章 地域および国の分析

• 世界の神経毒市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の神経毒市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 神経毒市場の競合情勢
• 神経毒市場の企業プロファイル
  • AbbVie Inc.
  • Galderma Inc.
  • Ipsen SA
  • Daewoong Pharmaceutical Co. Ltd.
  • Supernus Pharmaceuticals

第31章 その他の大手および革新的な企業

• Merz Pharma GmbH &Co KGaA
• Hugel Inc.
• Evolus Inc.
• Medytox Inc.
• Croma-Pharma GmbH
• Revance Therapeutics Inc.
• US WorldMeds
• Gufic Biosciences Ltd.
• Hironic Co. Ltd.
• Allergan
• List Biological Labs Inc.
• Lanzhou Institute of Biological Products Co. Ltd.
• Solstice Neurosciences
• Sinclair Pharma
• Vida Aesthetics

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

A neurotoxin is a substance specifically designed to be toxic to nerve cells (neurons) or the nervous system. These substances operate by inhibiting cellular processes within neurons.

The primary products classified as neurotoxins include well-known brands such as Botox, Dysport, Xeomin, and others. Botox, derived from the bacteria Clostridium botulinum, is a notable neurotoxin used for both cosmetic and medical purposes. It is employed to temporarily reduce the appearance of wrinkles and to treat certain muscular conditions. These neurotoxin products find applications in therapeutic and aesthetic contexts, with end-users ranging from hospitals and specialty clinics to dermatology clinics and other relevant healthcare facilities.

The neurotoxin market research report is one of a series of new reports from The Business Research Company that provides neurotoxin market statistics, including neurotoxin industry global market size, regional shares, competitors with a neurotoxin market share, detailed neurotoxin market segments, market trends and opportunities, and any further data you may need to thrive in the neurotoxin industry. This neurotoxin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neurotoxin market size has grown rapidly in recent years. It will grow from $6.74 billion in 2023 to $7.43 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. The expansion observed in the historical period can be attributed to several factors, including the increase in aesthetic procedures, the growing prevalence of therapeutic applications, advancements in the cosmetic industry, a rising aging population, and the increasing acceptance of non-surgical procedures.

The neurotoxin market size is expected to see rapid growth in the next few years. It will grow to $11.14 billion in 2028 at a compound annual growth rate (CAGR) of 10.7%. The anticipated growth in the forecast period can be attributed to the expanding applications in neurology, sustained demand for aesthetic procedures, innovations in formulations, increasing consumer awareness, and the expansion of cosmetic tourism. Notable trends expected in the forecast period include advancements in drug delivery techniques, collaborations for neurotoxin development and research, market responses to regulatory changes in the neurotoxin industry, the integration of neurotoxins in multimodal treatment plans, and a heightened focus on achieving long-lasting effects and ensuring patient satisfaction.

The anticipated growth in the neurotoxin market is expected to be propelled by the surge in cosmetic procedures aimed at improving appearance. Cosmetic procedures encompass a diverse range of medical interventions undertaken with the primary objective of enhancing or altering an individual's physical appearance. This trend is influenced by societal, technological, and cultural factors, coupled with increased awareness of the benefits associated with cosmetic procedures. Neurotoxins play a crucial role in these procedures by relaxing specific muscles, thereby reducing the appearance of wrinkles and fine lines. For instance, a cosmetic surgery survey by the American Society of Plastic Surgeons in August 2022 revealed a significant increase in demand for cosmetic procedures, with 3 out of 4 plastic surgeons in the USA noting a rise in demand, and 30% reporting a doubling of their cosmetic procedure businesses. This surge in cosmetic procedures to enhance appearance is a key driver fueling the growth of the neurotoxin market.

The growing aging population is expected to contribute to the expansion of the neurotoxin market. The term 'aging population' refers to a demographic trend characterized by an increasing proportion of elderly individuals within a society or population. As individuals age, they often turn to neurotoxin-based treatments, such as Botox, to address age-related cosmetic concerns such as wrinkles and facial lines. This demographic seeks non-invasive solutions to enhance their appearance and achieve a more youthful and rejuvenated aesthetic. According to the World Health Organization (WHO), the global population of people aged 60 years and older is growing rapidly, expected to double by 2050 and reach 2.1 billion. The growing aging population is thus a significant factor driving the growth of the neurotoxin market.

The innovation of facial aesthetic products is a notable trend gaining popularity in the neurotoxins market, with companies actively engaged in developing and introducing novel products to sustain their positions. One example is Evolus Inc., a US-based medical aesthetics company, which received approval from the Australian Therapeutic Goods Administration (TGA) in January 2023 for Nuceiva (prabotulinumtoxinA). Nuceiva is a neurotoxin specifically designed for aesthetic purposes, aiming to temporarily enhance the appearance of moderate glabellar lines in adult patients. By blocking nerve impulses to facial muscles, the product induces muscle relaxation, smoothing wrinkles resulting from facial expressions, squinting, and frowning.

Major companies operating in the neurotoxins market are emphasizing innovative products, including facial gel serums, with the goal of enhancing patient satisfaction. An example is the ready-to-use BoNT-A neuromodulator, a pre-formulated and prepared Botulinum Toxin Type A (BoNT-A) product. This product offers a convenient and standardized solution for healthcare practitioners in cosmetic or therapeutic applications. In September 2022, Entod Pharmaceuticals, an Indian-based pharmaceutical company, launched Vasuki, a facial gel serum based on synthetic tripeptide snake venom neurotoxin. The serum is formulated to gently relax muscle contractions under the skin, potentially reducing the appearance of wrinkles and fine lines.

In August 2021, Merz Pharma GmbH & Co. KGaA, a Germany-based pharmaceutical company in the neurotoxin market, entered into a strategic partnership agreement with Vensica Therapeutics Ltd., an Israel-based urology catheter designing and development company. The collaboration involves the delivery of botulinum neurotoxin A (Xeomin) to the bladder wall using Vensica's innovative ultrasound-assisted delivery catheter for urology applications. This strategic partnership reflects a commitment to advancing treatment options and delivery methods in the urology field through the combination of Merz's neurotoxin expertise and Vensica's innovative catheter technology.

Major companies operating in the neurotoxin market report are AbbVie Inc., Galderma Inc., Ipsen SA, Daewoong Pharmaceutical Co. Ltd., Supernus Pharmaceuticals, Merz Pharma GmbH & Co KGaA, Hugel Inc., Evolus Inc., Medytox Inc., Croma-Pharma GmbH, Revance Therapeutics Inc., US WorldMeds, Gufic Biosciences Ltd., Hironic Co. Ltd., Allergan, List Biological Laboratories, Lanzhou Institute of Biological Products Co. Ltd., Solstice Neurosciences, Sinclair Pharma, Vida Aesthetics, Aquavit Holdings LLC, PharmaResearch Products Co.Ltd., Entod Pharmaceuticals, Object Pharma Inc., Eisai Co. Ltd.

North America was the largest region in the neurotoxin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurotoxin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neurotoxin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neurotoxin market consists of sales of lead, ethanol (drinking alcohol), glutamate, nitric oxide, tetanus toxin, and tetrodotoxin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurotoxin Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neurotoxin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neurotoxin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neurotoxin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product Type: Botox; Dysport; Xeomin; Other Products
• 2) By Application: Therapeutic; Aesthetic
• 3) By End User: Hospitals; Specialty Clinics; Dermatology Clinics; Other End Users
• Companies Mentioned: AbbVie Inc.; Galderma Inc.; Ipsen SA; Daewoong Pharmaceutical Co. Ltd.; Supernus Pharmaceuticals
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neurotoxin Market Characteristics

3. Neurotoxin Market Trends And Strategies

4. Neurotoxin Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Neurotoxin Market Size and Growth

• 5.1. Global Neurotoxin Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Neurotoxin Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Neurotoxin Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Neurotoxin Market Segmentation

• 6.1. Global Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Botox
• Dysport
• Xeomin
• Other Products
• 6.2. Global Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Therapeutic
• Aesthetic
• 6.3. Global Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Specialty Clinics
• Dermatology Clinics
• Other End Users

7. Neurotoxin Market Regional And Country Analysis

• 7.1. Global Neurotoxin Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Neurotoxin Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Neurotoxin Market

• 8.1. Asia-Pacific Neurotoxin Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Neurotoxin Market

• 9.1. China Neurotoxin Market Overview
• 9.2. China Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Neurotoxin Market

• 10.1. India Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Neurotoxin Market

• 11.1. Japan Neurotoxin Market Overview
• 11.2. Japan Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Neurotoxin Market

• 12.1. Australia Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Neurotoxin Market

• 13.1. Indonesia Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Neurotoxin Market

• 14.1. South Korea Neurotoxin Market Overview
• 14.2. South Korea Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Neurotoxin Market

• 15.1. Western Europe Neurotoxin Market Overview
• 15.2. Western Europe Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Neurotoxin Market

• 16.1. UK Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Neurotoxin Market

• 17.1. Germany Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Neurotoxin Market

• 18.1. France Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Neurotoxin Market

• 19.1. Italy Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Neurotoxin Market

• 20.1. Spain Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Neurotoxin Market

• 21.1. Eastern Europe Neurotoxin Market Overview
• 21.2. Eastern Europe Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Neurotoxin Market

• 22.1. Russia Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Neurotoxin Market

• 23.1. North America Neurotoxin Market Overview
• 23.2. North America Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Neurotoxin Market

• 24.1. USA Neurotoxin Market Overview
• 24.2. USA Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Neurotoxin Market

• 25.1. Canada Neurotoxin Market Overview
• 25.2. Canada Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Neurotoxin Market

• 26.1. South America Neurotoxin Market Overview
• 26.2. South America Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Neurotoxin Market

• 27.1. Brazil Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Neurotoxin Market

• 28.1. Middle East Neurotoxin Market Overview
• 28.2. Middle East Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Neurotoxin Market

• 29.1. Africa Neurotoxin Market Overview
• 29.2. Africa Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Neurotoxin Market Competitive Landscape And Company Profiles

• 30.1. Neurotoxin Market Competitive Landscape
• 30.2. Neurotoxin Market Company Profiles
  • 30.2.1. AbbVie Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Galderma Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Ipsen SA
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Daewoong Pharmaceutical Co. Ltd.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Supernus Pharmaceuticals
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Neurotoxin Market Other Major And Innovative Companies

• 31.1. Merz Pharma GmbH & Co KGaA
• 31.2. Hugel Inc.
• 31.3. Evolus Inc.
• 31.4. Medytox Inc.
• 31.5. Croma-Pharma GmbH
• 31.6. Revance Therapeutics Inc.
• 31.7. US WorldMeds
• 31.8. Gufic Biosciences Ltd.
• 31.9. Hironic Co. Ltd.
• 31.10. Allergan
• 31.11. List Biological Labs Inc.
• 31.12. Lanzhou Institute of Biological Products Co. Ltd.
• 31.13. Solstice Neurosciences
• 31.14. Sinclair Pharma
• 31.15. Vida Aesthetics

32. Global Neurotoxin Market Competitive Benchmarking

33. Global Neurotoxin Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Neurotoxin Market

35. Neurotoxin Market Future Outlook and Potential Analysis

• 35.1 Neurotoxin Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Neurotoxin Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Neurotoxin Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer